Stockreport

Beam Therapeutics Unveils New Safety, Efficacy Data From Sickle Cell Disease Candidate, Stock Gains [Yahoo! Finance]

Beam Therapeutics Inc.  (BEAM) 
PDF The data were featured at the American Society of Hematology (ASH) Annual Meeting and Exposition. Consistent with Beam's previously announced data, updated data from [Read more]